White Paper
Controlling Cancer Care: The Emergence of Formulary Exclusions in Oncology
Sep 23, 2021
Using published national formularies and longitudinal claims data, this paper demonstrates the growing challenge of payer exclusions in oncology. Case studies in metastatic breast cancer further evaluate the impact these exclusions have on treatment initiation, demonstrating the need for action, measurement, and strategy across tumor types.